These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 9555661)

  • 1. CD59 protects glomerular endothelial cells from immune-mediated thrombotic microangiopathy in rats.
    Nangaku M; Alpers CE; Pippin J; Shankland SJ; Kurokawa K; Adler S; Morgan BP; Johnson RJ; Couser WG
    J Am Soc Nephrol; 1998 Apr; 9(4):590-7. PubMed ID: 9555661
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Renal microvascular injury induced by antibody to glomerular endothelial cells is mediated by C5b-9.
    Nangaku M; Alpers CE; Pippin J; Shankland SJ; Kurokawa K; Adler S; Johnson RJ; Couser WG
    Kidney Int; 1997 Dec; 52(6):1570-8. PubMed ID: 9407502
    [TBL] [Abstract][Full Text] [Related]  

  • 3. C5b-9 membrane attack complex mediates endothelial cell apoptosis in experimental glomerulonephritis.
    Hughes J; Nangaku M; Alpers CE; Shankland SJ; Couser WG; Johnson RJ
    Am J Physiol Renal Physiol; 2000 May; 278(5):F747-57. PubMed ID: 10807586
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Glomerular complement regulation is overwhelmed in passive Heymann nephritis.
    Cunningham PN; Hack BK; Ren G; Minto AW; Morgan BP; Quigg RJ
    Kidney Int; 2001 Sep; 60(3):900-9. PubMed ID: 11532085
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of CD59 in experimental glomerulonephritis in rats.
    Matsuo S; Nishikage H; Yoshida F; Nomura A; Piddlesden SJ; Morgan BP
    Kidney Int; 1994 Jul; 46(1):191-200. PubMed ID: 7523753
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A new model of renal microvascular endothelial injury.
    Nangaku M; Alpers CE; Pippin J; Shankland SJ; Adler S; Kurokawa K; Couser WG; Johnson RJ
    Kidney Int; 1997 Jul; 52(1):182-94. PubMed ID: 9211361
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Protective role of nitric oxide in a model of thrombotic microangiopathy in rats.
    Shao J; Miyata T; Yamada K; Hanafusa N; Wada T; Gordon KL; Inagi R; Kurokawa K; Fujita T; Johnson RJ; Nangaku M
    J Am Soc Nephrol; 2001 Oct; 12(10):2088-2097. PubMed ID: 11562407
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intravenous immunoglobulin protects against experimental thrombotic microangiopathy.
    Jefferson JA; Suga SI; Kim YG; Pippin J; Gordon KL; Johnson RJ; Couser WG
    Kidney Int; 2001 Sep; 60(3):1018-25. PubMed ID: 11532096
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Transfected CD59 protects mesangial cells from injury induced by antibody and complement.
    Nangaku M; Meek RL; Pippin J; Gordon KL; Morgan BP; Johnson RJ; Couser WG
    Kidney Int; 1996 Jul; 50(1):257-66. PubMed ID: 8807596
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CD59 (homologous restriction factor 20), a plasma membrane protein that protects against complement C5b-9 attack, in human atherosclerotic lesions.
    Seifert PS; Roth I; Schmiedt W; Oelert H; Okada N; Okada H; Bhakdi S
    Atherosclerosis; 1992 Oct; 96(2-3):135-45. PubMed ID: 1281630
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Composition of immune deposits present in glomeruli of NZB/W F1 mice.
    Sugisaki T; Takase S
    Clin Immunol Immunopathol; 1991 Dec; 61(3):296-308. PubMed ID: 1934620
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Respective roles of decay-accelerating factor and CD59 in circumventing glomerular injury in acute nephrotoxic serum nephritis.
    Lin F; Salant DJ; Meyerson H; Emancipator S; Morgan BP; Medof ME
    J Immunol; 2004 Feb; 172(4):2636-42. PubMed ID: 14764738
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Decay-accelerating factor but not CD59 limits experimental immune-complex glomerulonephritis.
    Bao L; Haas M; Minto AW; Quigg RJ
    Lab Invest; 2007 Apr; 87(4):357-64. PubMed ID: 17259999
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CD59 protects rat kidney from complement mediated injury in collaboration with crry.
    Watanabe M; Morita Y; Mizuno M; Nishikawa K; Yuzawa Y; Hotta N; Morgan BP; Okada N; Okada H; Matsuo S
    Kidney Int; 2000 Oct; 58(4):1569-79. PubMed ID: 11012891
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Regulatory control of the terminal complement proteins at the surface of human endothelial cells: neutralization of a C5b-9 inhibitor by antibody to CD59.
    Hamilton KK; Ji Z; Rollins S; Stewart BH; Sims PJ
    Blood; 1990 Dec; 76(12):2572-7. PubMed ID: 1702330
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Complement regulation in the rat glomerulus: Crry and CD59 regulate complement in glomerular mesangial and endothelial cells.
    Quigg RJ; Morgan BP; Holers VM; Adler S; Sneed AE; Lo CF
    Kidney Int; 1995 Aug; 48(2):412-21. PubMed ID: 7564108
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Glomerular handling of immune complex in the acute phase of active in situ immune complex glomerulonephritis employing cationized ferritin in rats. Ultrastructural localization of immune complex, complements and inflammatory cells.
    Fujigaki Y; Nagase M; Kojima K; Yamamoto T; Hishida A
    Virchows Arch; 1997 Jul; 431(1):53-61. PubMed ID: 9247633
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Complement regulator CD59 protects against atherosclerosis by restricting the formation of complement membrane attack complex.
    Wu G; Hu W; Shahsafaei A; Song W; Dobarro M; Sukhova GK; Bronson RR; Shi GP; Rother RP; Halperin JA; Qin X
    Circ Res; 2009 Feb; 104(4):550-8. PubMed ID: 19131645
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of the complement membrane attack complex (C5b-9) in mediating experimental mesangioproliferative glomerulonephritis.
    Brandt J; Pippin J; Schulze M; Hänsch GM; Alpers CE; Johnson RJ; Gordon K; Couser WG
    Kidney Int; 1996 Feb; 49(2):335-43. PubMed ID: 8821815
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A protein toxin from the sea anemone Phyllodiscus semoni targets the kidney and causes a severe renal injury with predominant glomerular endothelial damage.
    Mizuno M; Nozaki M; Morine N; Suzuki N; Nishikawa K; Morgan BP; Matsuo S
    Am J Pathol; 2007 Aug; 171(2):402-14. PubMed ID: 17600120
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.